Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 30S ribosomal subunit 16S rRNA A-site (aminoacyl-tRNA site) is a critical functional region within the small subunit of the bacterial ribosome [1]. It serves as the decoding center where the codon of the messenger RNA (mRNA) is matched with the anticodon of the incoming aminoacyl-transfer RNA (tRNA) [4]. This site ensures the fidelity of protein synthesis by monitoring the base-pairing between mRNA and tRNA [6]. Because of its essential role in bacterial translation, it is a primary target for several classes of antibiotics, most notably aminoglycosides and tetracyclines [2, 11]. Aminoglycosides bind to the A-site, inducing conformational changes—specifically the flipping out of nucleotides A1492 and A1493—that lead to the misreading of the genetic code or the premature termination of protein synthesis [3, 9]. Tetracyclines, on the other hand, physically block the binding of aminoacyl-tRNA to the A-site, thereby halting translation [5, 13]. Targeting this site is a cornerstone of treating various Gram-negative and Gram-positive bacterial infections [1]. However, resistance mechanisms such as rRNA methylation and specific mutations in the 16S rRNA pose significant clinical challenges [1, 14]. Additionally, drugs targeting this site can cause side effects like ototoxicity and nephrotoxicity in humans due to structural similarities with mitochondrial ribosomes [1, 13].
Aminoglycosides bind to the 16S rRNA A-site, causing misreading of mRNA and inhibition of translocation [2, 3]. Tetracyclines bind to the A-site to prevent the attachment of aminoacyl-tRNA, thereby inhibiting protein synthesis [4, 5].
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 30S ribosomal subunit 16S rRNA aminoacyl-tRNA site (A-site) (16S rRNA A-site).